ADAT3
protein-codingadenosine deaminase tRNA specific 3, the group of Adenosine deaminases acting on RNA
Gene summary
This gene encodes a subunit of a tRNA-specific adenosine deaminase. This heterodimeric enzyme converts adenosine to inosine in the tRNA anticodon. A mutation in this gene causes a syndrome characterized by intellectual disability and strabismus. This gene shares its 5' exon with the overlapping gene, secretory carrier membrane protein 4 (Gene ID: 113178). [provided by RefSeq, Jul 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014119
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014119
Submitter: ClinGen
*ADAT3* encodes the non-catalytic subunit of the heterodimeric ADAT2/ADAT3 tRNA deaminase complex, which catalyzes adenosine-to-inosine modification at position 34 of transfer RNAs, essential for accurate protein translation and decoding of C-ending codons. Biallelic loss-of-function variants in *ADAT3* cause autosomal recessive intellectual disability through deficient wobble inosine modification, leading to impaired protein synthesis that particularly affects neurodevelopment. Five different genetic variants identified so far include the highly recurrent p.Val144Met founder mutation found in over 90% of total reported patients, with 55 patients from 29 consanguineous families, predominantly from Middle Eastern countries (Alazami et al., PMID: 23620220; Del-Pozo-Rodriguez et al., PMID: 40120092), along with two missense variants (p.Ala196Val, p.Ala196Leu) (Ramos et al., PMID: 32763916; Thomas et al., PMID: 31687266), one frameshift variant (8-bp duplication causing p.Glu36Glyfs44) (Chaleshtori et al., PMID: 29796286), and one nonsense variant (p.Gln274*) (PMID: 32763916), found in homozygous and compound heterozygous states. Strong segregation evidence with maximum points awarded demonstrates co-segregation of variants with disease phenotype across multiple affected families. Clinical features consistently include intellectual disability (100%) and absent or severely delayed speech, with variable features such as microcephaly, seizures, muscle tone defects, and other features such as failure to thrive, strabismus, and dysmorphic facial features. Functional studies demonstrate that *ADAT3* variants reduce enzymatic activity, protein stability, and tRNA modification in patient cells, with rescue experiments confirming that catalytic function is essential for proper neuronal migration and cortical development. In summary, there is moderate evidence supporting the relationship between *ADAT3* and autosomal recessive intellectual disability-strabismus syndrome. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on September 16, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014119
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014119
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014119
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADAT3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_138422.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 20 | 2 | 22 | |||
| missense | 2 | 133 | 12 | 1 | 148 | |
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 3 | 2 | 6 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 5 | 137 | 32 | 3 | 178 |
Highest pathogenic variant AF is 0.0001902746
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_612431.2 | 1 | MANE Select | |
| Ensembl | ENSP00000332448.2 | 1 | MANE Select | |
| RefSeq | NP_001316462.1 | 1 | Standard | |
| Ensembl | ENSP00000404502.2 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- tRNA modification in the nucleus and cytosol
- tRNA processing
- Metabolism of RNA
Biological Process
- tRNA wobble adenosine to inosine editing
- tRNA processing
Molecular Function
- catalytic activity
- metal ion binding
- tRNA-specific adenosine-34 deaminase activity
Cellular Component
- nucleoplasm
- tRNA-specific adenosine-34 deaminase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000329478
- Coding exons
- 1
- Length
- 8068
- Individuals with no LoFs
- 120957
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 23
- Defined
- 120980
- p
- 0.0000951
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.422 | 235 | 217 | 1.08 | 0.0000171 | 2220 |
| Missense (PolyPhen) | 48 | 47.518 | 1.0101 | 507 | ||
| Synonymous | 0.214 | 103 | 106 | 0.974 | 0.00000912 | 822 |
| Loss of Function | 0.803 | 4 | 6.15 | 0.651 | 2.66e-7 | 76 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000030 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000058 | 0.000056 | rare |
| Finnish | 0.00022 | 0.00015 | rare |
| European (Non-Finnish) | 0.00013 | 0.00012 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Mental retardation, autosomal recessive 36 (MRT36) [MIM:615286]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT36 is often associated with esotropia and failure to thrive. Other more variable features included microcephaly, hypotonia, and mild brain abnormalities on MRI, such as dilated ventricles or delayed myelination. {ECO:0000269|PubMed:23620220}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.116
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.854
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |